Evidence map›Paper›PMID 28069942›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2017

A paradox of transcriptional and functional innate interferon responses of human intestinal enteroids to enteric virus infection.

Kapil Saxena, Lukas M Simon, Xi-Lei Zeng, Sarah E Blutt, Sue E Crawford, Narayan P Sastri, Umesh C Karandikar, Nadim J Ajami, Nicholas C Zachos, Olga Kovbasnjuk and 4 more

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 89 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
89citing papers in PubMed, 1 pooled it
11.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

89 citing papers in PubMed, 1 synthesis or guideline pooled it, 126 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Review
  12. Review
  13. Pathoimmunological analyses of fatal E11 infection in premature infants.Frontiers in cellular and infection microbiology · 2024
    Article
  14. Rotavirus-mediated DGAT1 degradation: A pathophysiological mechanism of viral-induced malabsorptive diarrhea.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article

29 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 1 country.

Kapil SaxenaDepartment of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX 77030.
Lukas M SimonDepartment of Human and Molecular Genetics, Baylor College of Medicine, Houston, TX 77030.
Xi-Lei ZengDepartment of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX 77030.
Sarah E BluttDepartment of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX 77030.
Sue E CrawfordDepartment of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX 77030.
Narayan P SastriDepartment of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX 77030.
Umesh C KarandikarDepartment of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX 77030.
Nadim J AjamiDepartment of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX 77030.
Nicholas C ZachosDepartment of Medicine, Gastroenterology Division, Johns Hopkins University School of Medicine, Baltimore, MD 21205.
Olga KovbasnjukDepartment of Medicine, Gastroenterology Division, Johns Hopkins University School of Medicine, Baltimore, MD 21205.
Mark DonowitzDepartment of Medicine, Gastroenterology Division, Johns Hopkins University School of Medicine, Baltimore, MD 21205.
Margaret E ConnerDepartment of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX 77030.
Chad A ShawDepartment of Human and Molecular Genetics, Baylor College of Medicine, Houston, TX 77030.
Mary K EstesDepartment of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX 77030; mestes@bcm.tmc.edu.
Baylor College of Medicine · USJohns Hopkins Medicine · USJohns Hopkins University · US

Funding

Tumor BiologyP30CA125123 · NCI · BAYLOR COLLEGE OF MEDICINE · PI Michael M Ittmann · 2007 to 2026
$73.9M
Institutional Clinical and Translational Science AwardUL1TR000003 · NCATS · UNIVERSITY OF PENNSYLVANIA · PI FITZGERALD, GARRET A · 2012 to 2015
$38.9M
Tissue Analysis & Molecular Imaging CoreP30DK056338 · NIDDK · BAYLOR COLLEGE OF MEDICINE · PI James Versalovic · 2001 to 2026
$28.3M
Virology CoreP30AI036211 · NIAID · BAYLOR COLLEGE OF MEDICINE · PI BUTEL, JANET S · 1994 to 2015
$21.7M
Novel Platforms for Human Intestinal Enteroids: Matrix, Mechanics, and TopographyU19AI116497 · NIAID · BAYLOR COLLEGE OF MEDICINE · PI BLUTT, SARAH E · 2015 to 2025
$13.2M
Translational Research Enhancement CoreP30DK089502 · NIDDK · JOHNS HOPKINS UNIVERSITY · PI ZACHOS, NICHOLAS CONSTANTINE · 2011 to 2020
$12.0M
Translational Approaches to Develop Drug Therapy for DiarrheaR24DK099803 · NIDDK · JOHNS HOPKINS UNIVERSITY · PI DONOWITZ, MARK · 2014 to 2019
$8.9M
Regulation of Rotavirus ReplicationR01AI080656 · NIAID · BAYLOR COLLEGE OF MEDICINE · PI Sue Ellen Crawford, Mary Kolb Estes · 2009 to 2026
$7.9M
Human Intestinal Organoids: Pre-Clinical Models of Non-Inflammatory DiarrheaU18TR000552 · NCATS · JOHNS HOPKINS UNIVERSITY · PI DONOWITZ, MARK · 2012 to 2014
$1.2M
Clostridium difficile Immunity: Role of IGA and GALTR21AI117220 · NIAID · BAYLOR COLLEGE OF MEDICINE · PI CONNER, MARGARET E. · 2015 to 2016
$436k
BD Biosciences Special Order LSRIIS10RR024574 · NCRR · BAYLOR COLLEGE OF MEDICINE · PI LUMPKIN, ELLEN A · 2009 to 2009
$430k
NCATS NIH HHS U18 TR000552NCATS NIH HHS UL1 TR000003NCI NIH HHS P30 CA125123NCRR NIH HHS S10 RR024574NIAID NIH HHS P30 AI036211NIAID NIH HHS R01 AI080656NIAID NIH HHS R21 AI117220NIAID NIH HHS U19 AI116497NIDDK NIH HHS P30 DK056338NIDDK NIH HHS P30 DK089502NIDDK NIH HHS R24 DK099803
6 · The paper itself

Abstract

The intestinal epithelium can limit enteric pathogens by producing antiviral cytokines, such as IFNs. Type I IFN (IFN-α/β) and type III IFN (IFN-λ) function at the epithelial level, and their respective efficacies depend on the specific pathogen and site of infection. However, the roles of type I and type III IFN in restricting human enteric viruses are poorly characterized as a result of the difficulties in cultivating these viruses in vitro and directly obtaining control and infected small intestinal human tissue. We infected nontransformed human intestinal enteroid cultures from multiple individuals with human rotavirus (HRV) and assessed the host epithelial response by using RNA-sequencing and functional assays. The dominant transcriptional pathway induced by HRV infection is a type III IFN-regulated response. Early after HRV infection, low levels of type III IFN protein activate IFN-stimulated genes. However, this endogenous response does not restrict HRV replication because replication-competent HRV antagonizes the type III IFN response at pre- and posttranscriptional levels. In contrast, exogenous IFN treatment restricts HRV replication, with type I IFN being more potent than type III IFN, suggesting that extraepithelial sources of type I IFN may be the critical IFN for limiting enteric virus replication in the human intestine.

Indexed as

AnimalsCell LineChlorocebus aethiopsHumansImmunity, InnateInterferonsIntestine, SmallRotavirusRotavirus InfectionsSequence Analysis, RNAVirus ReplicationInterferonsenteric virushuman enteroidshuman rotavirusinterferon

Identifiers

PMID28069942
PMCPMC5278484
OpenAlexW2568145394

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.